Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - OptiNose, Inc. | optn12-31x202010xkex322.htm |
| EX-32.1 - EX-32.1 - OptiNose, Inc. | optn12-31x202010xkex321.htm |
| EX-31.2 - EX-31.2 - OptiNose, Inc. | optn12-31x202010xkex312.htm |
| EX-31.1 - EX-31.1 - OptiNose, Inc. | optn12-31x202010xkex311.htm |
| EX-10.23 - EX-10.23 - OptiNose, Inc. | pharmakon-optinosexxfirsta.htm |
| EX-10.1 - EX-10.1 - OptiNose, Inc. | formindemnificationagreeme.htm |
| 10-K - 10-K - OptiNose, Inc. | optn-20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-8 No. 333-221047) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(2)Registration Statement (Form S-8 No. 333-223617) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(3)Registration Statement (Form S-8 No. 333-230083) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(4)Registration Statement (Form S-8 No. 333-236978) pertaining to the Amended and Restated 2020 Stock Incentive Plan, the Non-Qualified Stock Option Award (Inducement Grant) and the Restricted Stock Unit Award (Inducement Grant) of OptiNose, Inc.
(5)Registration Statement (Form S-3 No. 333-228122) of OptiNose, Inc.
of our report dated March 3, 2021, with respect to the consolidated financial statements of OptiNose, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 3, 2021